David Mott

Type: Person

Name: David Mott

Title: Chief Executive Officer , Medlmmune

company: AstraZeneca PLC

Nationality: United Kingdom

Fact Sheet: Biography for David Mott

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Mott's

Cydan, the NEA Startup Machine, Scours the Globe for Orphan Drugs

Home » Blogs » What if you could create a biotech startup focused on treating a rare disease, with a drug candidate already in hand, and high odds of success in clinical trials? That’s the concept that crystallized in former MedImmune executive David ... [Published BioPortfolio - Apr 25 2013]

Entities: Startup, Drugs, Biotechnology, David Mott, Mott's

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

What went wrong at Ten Breakfast?

With the dust settled on Ten’s failed entry into the morning television market, Lee Zachariah sifts through the rubble to find out what really went wrong with Breakfast in a feature that first appeared in Encore.A billboard tells a thousand words. In ... [Published Mumbrella - Apr 23 2013]

Entities: Paul Henry, Andrew Rochford, Shaun Micallef

First reported Apr 17 2013 - Updated Apr 17 2013 - 1 reports

New Enterprise Associates

'Orphan drugs' in search of a home: NEA funds accelerator to fight rare diseases

You don't normally think of drugs and business accelerators. NEA is out to change that. ShutterstockRate this storyMore from Hatchedby Kent Bernhard Jr. , Upstart Business Journal Money & Finance Editor April 17, 2013 | 9:01am EDTVenture giant New ... [Published Upstart Business Journal - Apr 17 2013]

Entities: New Enterprise Associates, Drugs, David Mott

First reported Apr 11 2013 - Updated Apr 11 2013 - 1 reports

Health accelerator gets $16M to find cures for rare diseases

This story is part of a series exploring the themes of our upcoming health tech conference ,May 20-21 in San Francisco. Read the full series here . Venture firm New Enterprise Associates hopes to find new cures for rare diseases with its ... [Published Venturebeat - Apr 11 2013]

Entities: New Enterprise Associates, Rare Genomics Institute, David Mott, Alexandria Real Estate Equities Inc

First reported Mar 13 2013 - Updated Mar 13 2013 - 1 reports

JDS Uniphase Corporation

Oxford Capital Exits Arieso in $85m Deal

Specialist growth capital investor Oxford Capital has exited mobile network optimisation business, Arieso , in an $85 million deal. The sale realised returns of up to 4.7x for investors. PRESS RELEASE Specialist growth capital investor Oxford ... [Published PE Hub News - Mar 13 2013]

Entities: Oxford Capital Corp, Oxford Capital Partners Inc, JDS Uniphase Corporation, David Mott

Quotes

In a statement from Ten announcing the Breakfast presenting line-up, then chief programming officer David Mott said of Henry: "while you can’t ever be sure what paul will do, when he’s on air, you know he’s going to tackle the elephant in the room."

What went wrong at Ten Breakfast? [Published Mumbrella - Apr 23 2013]

More Content

sort by: Date \| Relevance
Cydan, the NEA Startup Machine, Scours the Glob... [Published BioPortfolio - Apr 25 2013]
What went wrong at Ten Breakfast? [Published Mumbrella - Apr 23 2013]
'Orphan drugs' in search of a home: NEA funds a... [Published Upstart Business Journal - Apr 17 2013]
Cydan Launches New Orphan Drug Accelerator, Sec... [Published Pharmacy Choice - Apr 16 2013]
Cydan Launches New Orphan Drug Accelerator, Sec... [Published Zecco - Apr 16 2013]
Health accelerator gets $16M to find cures for ... [Published Venturebeat - Apr 11 2013]
Cydan Launches with $16M in Backing [Published PE Hub News - Apr 11 2013]
The Next Don: How VCs Plan For The Future [Published TechCrunch - Apr 06 2013]
The Next Don: How VCs Plan For The Future [Published TechCrunch Europe - Apr 06 2013]
Oxford Capital Exits Arieso in $85m Deal [Published PE Hub News - Mar 13 2013]
Biography for David Mott [Published Able2Act - Dec 17 2007]

Blogs

sort by: Date \| Relevance
Health accelerator gets $16M to find cures for ... [Published Venturebeat - Apr 11 2013] This story is part of a series exploring the themes of our upcoming health tech conference ,May 20-21 in San Francisco. Read the full series here . Venture firm New Enterprise Associates hopes to find new cures for rare diseases with its ...
The Next Don: How VCs Plan For The Future [Published TechCrunch - Apr 06 2013] We all remember the last scene in The Godfather, where Michael Corleone is depicted as the next Don, taking over the role from his father as the figurehead of the mafioso Corleone family. As a viewer, we are partly left with a sense of relief — finally, ...
The Next Don: How VCs Plan For The Future [Published TechCrunch Europe - Apr 06 2013] We all remember the last scene in The Godfather, where Michael Corleone is depicted as the next Don, taking over the role from his father as the figurehead of the mafioso Corleone family. As a viewer, we are partly left with a sense of relief — finally, ...

About
Silobreaker
Press Room

Products
Online Service
On-Premises Software

Contact Us
Sales
Support

Legal
Terms of Use
Privacy Policy

Some image thumbnails are sourced from Freebase, licensed under CC-BY
Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.